Aviat Networks (AVNW) SVP exercises options, sells 6,914 shares

Rhea-AI Filing Summary

Aviat Networks, Inc. SVP of Product and Innovation Gary Croke reported an option exercise and share sale. On February 6, 2026, he exercised a non-qualified stock option for 6,914 shares of common stock at $7.23 per share, then sold 6,914 shares at a weighted average price of $26.2039 under a Rule 10b5-1 trading plan. After these transactions, he directly owned 43,868 shares of Aviat Networks common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Croke Gary

(Last) (First) (Middle)

AVIAT NETWORKS, INC.

200 PARKER DRIVE, SUITE C100A

(Street)

AUSTIN TX 78728

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AVIAT NETWORKS, INC. [ AVNW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP of Product and Innovation

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/06/2026		M(1)		6,914	A	$7.23	50,782	D
Common Stock	02/06/2026		S(1)		6,914	D	$26.2039(2)	43,868	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$7.23	02/06/2026		M			6,914	09/20/2022(3)	09/20/2026	Common Stock	6,914	$0	0	D

Explanation of Responses:

1. The option exercise and sales reported were pursuant to Rule 10b5-1 trading plan by reporting person.

2. The price in Column 4 is a weighted average price. and shares sold in multiple transactions at prices ranging from $26.00 to $26.35.

3. The Stock Option was granted on September 20, 2019 and vested three years from date of grant.

Remarks:

	/s/ Jonanna Mikulenka, as attorney-in-fact	02/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Aviat Networks (AVNW) executive Gary Croke report in this Form 4?

Gary Croke, SVP of Product and Innovation at Aviat Networks, reported exercising options for 6,914 shares at $7.23 and selling 6,914 common shares at a weighted average price of $26.2039, all under a Rule 10b5-1 trading plan.

How many Aviat Networks (AVNW) shares did Gary Croke sell and at what price?

Gary Croke sold 6,914 Aviat Networks common shares at a weighted average price of $26.2039 per share. Footnotes state the sale occurred in multiple trades at prices ranging from $26.00 to $26.35 on February 6, 2026.

How many Aviat Networks (AVNW) shares does Gary Croke own after the reported transactions?

After the reported option exercise and share sale, Gary Croke directly owned 43,868 shares of Aviat Networks common stock. This figure reflects his holdings following the February 6, 2026 transactions disclosed in the Form 4 filing.

What stock option activity did Aviat Networks (AVNW) executive Gary Croke disclose?

Gary Croke exercised a non-qualified stock option for 6,914 shares of Aviat Networks common stock at an exercise price of $7.23 per share. The option was originally granted on September 20, 2019 and vested three years from the grant date.

Was the Aviat Networks (AVNW) insider transaction under a Rule 10b5-1 plan?

Yes. A footnote explains that both the option exercise and the related stock sales were carried out under a Rule 10b5-1 trading plan established by the reporting person, indicating a pre-arranged schedule for these transactions.